158 related articles for article (PubMed ID: 31687861)
1. Symptoms of mast cell activation syndrome in functional gastrointestinal disorders.
Wilder-Smith CH; Drewes AM; Materna A; Olesen SS
Scand J Gastroenterol; 2019 Nov; 54(11):1322-1325. PubMed ID: 31687861
[No Abstract] [Full Text] [Related]
2. The spectra, symptom profiles and overlap of Rome III functional gastrointestinal disorders in a tertiary center in South China.
Xiong LS; Shi Q; Gong XR; Cui Y; Chen MH
J Dig Dis; 2014 Oct; 15(10):538-44. PubMed ID: 25102919
[TBL] [Abstract][Full Text] [Related]
3. The overlap of upper functional gastrointestinal disorders with irritable bowel syndrome in Chinese outpatients: A multicenter study.
Yao X; Yang YS; Cui LH; Sun G; Peng LH; Wang WF; Hyder Q; Zhang XL
J Gastroenterol Hepatol; 2016 Sep; 31(9):1584-93. PubMed ID: 26875585
[TBL] [Abstract][Full Text] [Related]
4. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.
von Wulffen M; Talley NJ; Hammer J; McMaster J; Rich G; Shah A; Koloski N; Kendall BJ; Jones M; Holtmann G
Dig Dis Sci; 2019 Feb; 64(2):480-486. PubMed ID: 30368683
[TBL] [Abstract][Full Text] [Related]
5. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping.
Nakajima S; Takahashi K; Sato J; Fukuda M; Yamamoto K; Inoue T; Okumura Y; Fujiyama Y
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S138-43. PubMed ID: 20586856
[TBL] [Abstract][Full Text] [Related]
6. Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome (IBS).
Karpe AV; Liu JW; Shah A; Koloski N; Holtmann G; Beale DJ
Metabolomics; 2022 Jun; 18(6):38. PubMed ID: 35687195
[TBL] [Abstract][Full Text] [Related]
7. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review.
Burns G; Carroll G; Mathe A; Horvat J; Foster P; Walker MM; Talley NJ; Keely S
Am J Gastroenterol; 2019 Mar; 114(3):429-436. PubMed ID: 30839392
[TBL] [Abstract][Full Text] [Related]
8. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders?
Andresen V; Camilleri M; Kim HJ; Stephens DA; Carlson PJ; Talley NJ; Saito YA; Urrutia R; Zinsmeister AR
Gastroenterology; 2006 Jun; 130(7):1985-94. PubMed ID: 16762621
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan.
Okumura T; Tanno S; Ohhira M; Tanno S
J Gastroenterol; 2010 Feb; 45(2):187-94. PubMed ID: 19997854
[TBL] [Abstract][Full Text] [Related]
10. Sleep Quality of Functional Gastrointestinal Disorder Patients in Class-Three Hospitals: A Cross-Sectional Study in Tianjin, China.
Zhao W; Jin H; Xu M; Wang D; Liu Y; Tang Y; Zhang Q; Hua J; Wang B
Biomed Res Int; 2018; 2018():3619748. PubMed ID: 29977909
[TBL] [Abstract][Full Text] [Related]
11. Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT.
Ivashkin VT; Poluektova EA; Glazunov AB; Putilovskiy MA; Epstein OI
BMC Gastroenterol; 2019 Dec; 20(1):2. PubMed ID: 31892312
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID).
Vasapolli R; Schulz C; Schweden M; Casèn C; Kirubakaran GT; Kirste KH; Macke L; Link A; Schütte K; Malfertheiner P
Eur J Clin Invest; 2021 Dec; 51(12):e13666. PubMed ID: 34390492
[TBL] [Abstract][Full Text] [Related]
13. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
Choi YJ; Kim N; Yoon H; Shin CM; Park YS; Kim JW; Kim YS; Lee DH; Jung HC
J Gastroenterol Hepatol; 2017 Sep; 32(9):1553-1561. PubMed ID: 28160607
[TBL] [Abstract][Full Text] [Related]
14. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population.
Rasmussen S; Jensen TH; Henriksen SL; Haastrup PF; Larsen PV; Søndergaard J; Jarbøl DE
Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975
[TBL] [Abstract][Full Text] [Related]
15. Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management.
Hamilton MJ
Curr Gastroenterol Rep; 2024 Apr; 26(4):107-114. PubMed ID: 38353900
[TBL] [Abstract][Full Text] [Related]
16. Herbal Preparation STW 5 for Functional Gastrointestinal Disorders: Clinical Experience in Everyday Practice.
Lapina TL; Trukhmanov AS
Dig Dis; 2017; 35 Suppl 1():30-35. PubMed ID: 29421814
[TBL] [Abstract][Full Text] [Related]
17. Impact of Overlapping Functional Gastrointestinal Disorders on the Presentation and Quality of Life of Patients with Erosive Esophagitis and Nonerosive Reflux Disease.
Lee SW; Chang CS; Lien HC; Peng YC; Wu CY; Yeh HZ
Med Princ Pract; 2015; 24(5):491-5. PubMed ID: 26137901
[TBL] [Abstract][Full Text] [Related]
18. Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study.
Koloski NA; Jones M; Talley NJ
Aliment Pharmacol Ther; 2016 Sep; 44(6):592-600. PubMed ID: 27444264
[TBL] [Abstract][Full Text] [Related]
19. The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders.
Vu J; Kushnir V; Cassell B; Gyawali CP; Sayuk GS
Neurogastroenterol Motil; 2014 Sep; 26(9):1323-32. PubMed ID: 25070610
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of overlap syndromes and symptoms in pediatric functional dyspepsia.
Friesen CA; Rosen JM; Schurman JV
BMC Gastroenterol; 2016 Jul; 16(1):75. PubMed ID: 27457769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
